AMPEL BioSolutions Co-Founder and COO/CSO, Dr. Amrie Grammer guests on BioTalk to discuss building the Company in Charlottesville, VA, her work and recognition at NIH, and being a leader from the southern part of the BioHealth Capital Region.

Dr. Amrie Grammer is the Majority Owner and Co-Founder of AMPEL BioSolutions, located in downtown Charlottesville Virginia. Amrie is a Translational Immunologist specializing in human Autoimmune Diseases. She trained at UVA (BS Chemistry, MS Pharmacology) before receiving her PhD in Immunology at UTSW Medical Center at Dallas. Amrie was recruited to the NIH to establish the B Cell Biology Group in the Autoimmunity Branch of NIAMS during the human genome sequencing project. She received multiple NIH awards for her work comparing signaling pathways and genes expressed in patients vs healthy individuals, including the prestigious Director’s Award.

Amrie founded AMPEL in 2013 to bring precision medicine to individual patients, especially those suffering from lupus to whom she has dedicated her career. Over the last six years, she has used her knowledge to design and implement a pipeline to predict disease activity and the “right drug for the right patient at the right time”. In addition, top drugs she identified for repositioning into lupus have had positive clinical trials. Amrie is a member of Sigma Xi and Sigma Delta Epsilon. She serves as a Chair of the UVA Alumni Board of the professional Chemistry Fraternity, Alpha Chi Sigma. In December 2016, Amrie was elected to the Board of Directors of the Virginia Biotechnology Association (VA Bio). She is also a board member of the University of Virginia Fralin Art Museum (2011-present).

Listen now on Google Play bit.ly/2CzdnA9, iTunes, apple.co/2Arsfze, TuneIn bit.ly/2M60Wmx.